What is Diptheria Vaccine Market Scope?
Diphtheria can be described as an infection which is caused by the bacterium Corynebacterium diphtheria. This disease can lead to severe problems such as inflammation of nerves, myocarditis, kidney problems, and bleeding problems, caused due to low levels of platelets. Diphtheria vaccine’s function is to block the expansion of Corynebacterium diphtheriae and is highly efficient in killing it. One of the biggest advantages of this vaccine is that it is free from side effects, as a result of this, it is very safe to be used in pregnant woman and low-immunity individuals. The growing incidence of diphtheria, tetanus, and pertussis coupled with rising worldwide governmental support for the vaccination programs is driving the growth of the global Diptheria vaccine market.
The Diptheria Vaccine market study is being classified by Type (Daptacel, Infanrix, Kinrix, Pediarix, Pentacel and Quaracel) and major geographies with country level break-up.
Research Analyst at AMA predicts that Players from European and United States will contribute to the maximum growth of Global Diptheria Vaccine market throughout the predicted period.
GlaxoSmithKline plc (United Kingdom), Sanofi Pasteur (France), Protein Sciences Corporation (United States), Novartis AG (Switzerland), Merck & Co., Inc. (United States), Pfizer Inc. (United States), Astellas Pharma Inc. (Japan), AstraZeneca (United Kingdom), Johnson & Johnson (United States) and Emergent Biosolution Inc. (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are AJ Vaccines (Denmark), Bionet-Asia (Thailand), Massbiologics (United States), KM biologics co., Ltd. (Japan), Panacea Biotec Ltd. (India) and Serum Institute of India Pvt. Ltd. (India).
Analyst at AMA have segmented the market study of Global Diptheria Vaccine market by Type, Application and Region.
On the basis of geography, the market of Diptheria Vaccine has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
Market Influencers and their development strategies
On 22nd June 2020, Pfizer Inc has announced the initiation of four Phase 3 clinical trials within its current pipeline of investigational vaccines. With safety and tolerability of the investigational vaccine in infants and include a control group of Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]).
On 26th December 2018, VAXELIS, a joint-partnership between Sanofi and MSD, known as Merck inside the United States and Canada. the company has announced that The U.S. Food and Drug Administration has approved VAXELIS(TM) (Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus, Haemophilus b Conjugate Meningococcal Protein Conjugate, and Hepatitis B Recombinant Vaccine) for use in children from 6 weeks through 4 years of age (prior to the 5th birthday).
Influencing Market Trend
- Technological Advancement and Development in Vaccine Development
- Growth in Government and Non-Government Initiatives for Vaccine Development
- Increasing in Awareness among People Regarding Diptheria Vaccine
- Rising Investing in R&D activities by Various Vaccine Manufacturers, Growing Awareness, and Subsequent Demand for Diptheria Vaccine
- High Cost of Vaccine Development
- Inadequate access to Vaccines in Under Developed Countries
Key Target AudienceDiptheria Vaccine Manufacturers, Research Organizations and Consulting Companies, Potential Technology Investors, Regulatory & Government Bodies, Downstream Vendors, End Users and Others
Customization available in this Study:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research & Media features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.